Targeting Hsc70-based autophagy to eliminate amyloid β oligomers
Copyright © 2020 Elsevier Inc. All rights reserved..
Amyloid β (Aβ) oligomers may be a real culprit in the pathogenesis of Alzheimer's disease (AD); therefore, the elimination of these toxic oligomers may be of great significance for AD therapy. Autophagy is the catabolic process by which lysosomes degrade cytosolic components, and heat shock cognate 70 kDa protein (Hsc70) binds to proteins with their KFERQ-like motifs [also known as chaperone-mediated autophagy (CMA) motifs] and carries them to lysosomes through CMA or late endosomes through endosomal microautophagy (eMI) for degradation. In this study, our strategy is to make the pathological Aβ become one selective and suitable substrate for CMA and eMI (termed as Hsc70-based autophagy) by tagging its oligomers with multiple CMA motifs. First, we design and synthesize Aβ oligomer binding peptides with three CMA motifs. Second, we determine that the peptide can help Aβ oligomers enter endosomes and lysosomes, which can be further enhanced by ketone. More importantly, we find that the peptide can dramatically reduce Aβ oligomers in induced pluripotent stem cell (iPSC) cortical neurons derived from AD patient fibroblasts and protect primary cultured cortical neurons against the Aβ oligomer-induced neurotoxicity. In conclusion, we demonstrate that the peptide targeting Hsc70-based autophagy can effectively eliminate Aβ oligomers and have superior neuroprotective activity.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:524 |
---|---|
Enthalten in: |
Biochemical and biophysical research communications - 524(2020), 4 vom: 16. Apr., Seite 923-928 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Dou, Juan [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 20.10.2020 Date Revised 14.05.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.bbrc.2020.02.016 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM306515431 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM306515431 | ||
003 | DE-627 | ||
005 | 20231225123532.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.bbrc.2020.02.016 |2 doi | |
028 | 5 | 2 | |a pubmed24n1021.xml |
035 | |a (DE-627)NLM306515431 | ||
035 | |a (NLM)32057360 | ||
035 | |a (PII)S0006-291X(20)30282-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Dou, Juan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Targeting Hsc70-based autophagy to eliminate amyloid β oligomers |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.10.2020 | ||
500 | |a Date Revised 14.05.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Elsevier Inc. All rights reserved. | ||
520 | |a Amyloid β (Aβ) oligomers may be a real culprit in the pathogenesis of Alzheimer's disease (AD); therefore, the elimination of these toxic oligomers may be of great significance for AD therapy. Autophagy is the catabolic process by which lysosomes degrade cytosolic components, and heat shock cognate 70 kDa protein (Hsc70) binds to proteins with their KFERQ-like motifs [also known as chaperone-mediated autophagy (CMA) motifs] and carries them to lysosomes through CMA or late endosomes through endosomal microautophagy (eMI) for degradation. In this study, our strategy is to make the pathological Aβ become one selective and suitable substrate for CMA and eMI (termed as Hsc70-based autophagy) by tagging its oligomers with multiple CMA motifs. First, we design and synthesize Aβ oligomer binding peptides with three CMA motifs. Second, we determine that the peptide can help Aβ oligomers enter endosomes and lysosomes, which can be further enhanced by ketone. More importantly, we find that the peptide can dramatically reduce Aβ oligomers in induced pluripotent stem cell (iPSC) cortical neurons derived from AD patient fibroblasts and protect primary cultured cortical neurons against the Aβ oligomer-induced neurotoxicity. In conclusion, we demonstrate that the peptide targeting Hsc70-based autophagy can effectively eliminate Aβ oligomers and have superior neuroprotective activity | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
650 | 4 | |a Alzheimer’s disease | |
650 | 4 | |a Aβ oligomers | |
650 | 4 | |a Chaperone-mediated autophagy | |
650 | 4 | |a Hsc70 | |
650 | 7 | |a Amyloid beta-Peptides |2 NLM | |
650 | 7 | |a HSC70 Heat-Shock Proteins |2 NLM | |
650 | 7 | |a Neuroprotective Agents |2 NLM | |
650 | 7 | |a Peptides |2 NLM | |
700 | 1 | |a Su, Peng |e verfasserin |4 aut | |
700 | 1 | |a Xu, Chongchong |e verfasserin |4 aut | |
700 | 1 | |a Wen, Zhexing |e verfasserin |4 aut | |
700 | 1 | |a Mao, Zixu |e verfasserin |4 aut | |
700 | 1 | |a Li, Wenming |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biochemical and biophysical research communications |d 1960 |g 524(2020), 4 vom: 16. Apr., Seite 923-928 |w (DE-627)NLM000000035 |x 1090-2104 |7 nnns |
773 | 1 | 8 | |g volume:524 |g year:2020 |g number:4 |g day:16 |g month:04 |g pages:923-928 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bbrc.2020.02.016 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 524 |j 2020 |e 4 |b 16 |c 04 |h 923-928 |